Testimonials

“We have been working with Phetairos for c. 12 months they have been instrumental in providing clinical and regulatory support as we progress our lead compound into first in human studies both in healthy volunteers as well as patients. Phetairos have supported us with MHRA discussions, protocol design, selection of an appropriate phase 1 unit and CTA application. We look forward to continue working with Phetairos during the development of our lead compound.”